Session 31 - 12th CROI

Home

Session 31 Oral Abstracts
Hepatitis Virus Co-Infection
Thursday, 4 - 6 pm
Auditorium

4:00 pm 118	Comparison of Hepatitis C Virus-specific T-cell Responses in Peripheral Blood of Subjects with Chronic HCV Infection with versus without HIV Co-infection When Blocking the Cytokines Involved in Suppressor Activity Nadia Alatrakchi*¹, C S Graham¹, K E Sherman², and M J Koziel¹ ¹Boston, MA, USA and ²Cincinnati, OH, USA
4:15 pm 119	Evidence for a Defect in the HCV-specific CD4+ T-cell Response in HIV/HCV Co-infected Individuals Occurring at Early Stage of HIV Infection Valerie Dutoit*, D Ciuffreda, J J Gonvers, and G Pantaleo Univ Hosp, Lausanne, Switzerland
4:30 pm 120	Can Routine Non-invasive Tests Predict Liver Histology in HIV/HCV Co-infection? Analysis of Patients Entering the AIDS PEGASYS Ribavirin International Co-infection Trial (APRICOT) Richard Sterling*¹, E Lissen², N Clumeck³, R Sola⁴, M Correa⁵, J Montaner⁶, M Sulkowski⁷, F Torriani⁸, D Dieterich⁹, D Thomas⁷, D Messinger¹⁰, and M Nelson¹¹ ¹Virginia Commonwealth Univ Hlth System, Richmond, USA; ²Virgen del Rocío Univ Hosp, Seville, Spain; ³Ctr Hosp Univ St-Pierre, Brussels, Belgium; ⁴Hosp del Mar, Univ Autónoma de Barcelona, Spain; ⁵HCFMUSP, Casa da AIDS, Sao Paulo, Brazil; ⁶Univ of British Columbia, Vancouver, Canada; ⁷Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; ⁸Univ of California, San Diego, Treatment Ctr, USA; ⁹Mt Sinai Sch of Med, New York, NY, USA; ¹⁰IST GmbH, Mannheim, Germany; and ¹¹Chelsea and Westminster Hosp, London, UK
4:45 pm 121	Unexpected Significant Liver Disease among HIV/HCV-coi-nfected Persons with Minimal Fibrosis on Initial Liver Biopsy Mark Sulkowski*, S Mehta, M Torbenson, R Moore, and D Thomas Johns Hopkins Univ, Baltimore, MD, USA
5:00 pm 122	Homosexually Transmitted HCV Acute Infection Related to a Clustered Genotype 4 HCV in HIV-1-infected Men and Inefficacy of Early Antiviral Therapy Marie-Laure Chaix*¹, J Serpaggi², D Batisse³, C Dupont⁴, A Vallet-Pichard², H Fontaine², J P Viard⁵, C Piketty³, E Rouveix⁴, C Rouzioux¹, L Weiss³, and S Pol² ¹Univ Rene Descartes, Ctr Hosp Univ Necker, Paris, France; ²INSERM U370, Ctr Hosp Univ Necker, Paris, France; ³Ctr Hosp Univ Georges Pompidou, Paris, France; ⁴Ctr Hosp Univ Ambroise Paré, Boulogne, France; and ⁵Ctr Hosp Univ Necker, Paris, France
5:15 pm 123	Entecavir in HIV/HBV-co-infected Patients: Safety and Efficacy in a Phase II Study (ETV-038) W Pessoa¹, B Gazzard², A Huang³, C Brandao-Mello⁴, L Cassetti⁵, M Correa⁶, V Soriano⁷, P Phiri⁸, A Hall⁸, E Ledesma⁸, and R Wilber⁸ ¹Inst of Infectologia 'Emilio Ribas', Sao Paulo, Brazil; ²Chelsea and Westminster Hosp, London, UK; ³Univ of Louisville, KY, USA; ⁴Hosp Gaffrée e Guinle, Rio de Janeiro, Brazil; ⁵Fndn del Centro de Estudios Infectológicos, Buenos Aires, Argentina; ⁶Univ of São Paulo Med Sch, Brazil; ⁷Inst de Salud Carlos III, Madrid, Spain; and ⁸Bristol-Myers Squibb, Wallingford, CT, USA
5:30 pm 124	Tenofovir Disoproxil Fumarate Is Not Inferior to Adefovir Dipivoxil for the Treatment of Hepatitis B Virus in Subjects Who Are Co-infected with HIV: Results of ACTG A5127 Marion Peters*¹, J Anderson², P Lynch³, J Jacobson⁴, K Sherman⁵, B Alston Smith⁶, S Swindells⁷, T Liu², V Johnson⁸, R Pollard⁹, J Rooney¹⁰, B polsky⁴, and AACTG 5127 team ¹San Francisco, CA, USA; ²Boston, MA, USA; ³Chicago, IL, USA; ⁴New York, NY, USA; ⁵Cincinnati, OH, USA; ⁶Bethesda, MD, USA; ⁷Omaha, NE, USA; ⁸Birmingham, AL, USA; ⁹Univ of California, Davis, USA; and ¹⁰Foster City, CA, USA